Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganoderma Lucidum Spore with Chemotherapy in NSCLC
NCT02844114Phase 2Unknown
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Dietary Supplement
- Countries
- 1
01
Overview
A Phase 2 trial of ganoderma lucidum spore in non-small cell lung carcinoma (NSCLC). Status: unknown.
02
Drugs
ganoderma lucidum spore
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT02844114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844114.